GameStop Corp. (GME) Stock Price Today
Amgen downgraded after Novartis trial failure raises doubts on cholesterol drug prospects
Investment firm BMO Capital downgraded Amgen's stock from "Outperform" to "Market Perform" following a major clinical trial failure by Novartis for a similar cholesterol drug. Novartis' drug pelacarsen failed in a late-stage Phase III trial, casting ...
Al Shams plans to nominate new directors at Braemar amid concerns over governance and a tight nomination window.
Al Shams Investments, the largest shareholder of Braemar Hotels & Resorts, announced its intention to nominate a full slate of independent directors to the company's board. This move follows Braemar's announcement of a compressed nomination window co...
Novartis shares drop after late-stage drug trial failures, but long-term growth outlook remains intact
Novartis shares fell sharply following the failure of its late-stage drug candidates pelacarsen and del-desiran in phase 3 trials, which impacts the company’s near-term growth prospects. Despite these setbacks, Novartis reaffirmed its revenue growth ...
Meta's ad growth accelerates amid $130B capex, stock at a buy level signaling potential rebound.
Meta Platforms is experiencing strong ad revenue growth with a 28% increase in Q2 2026, driven by AI enhancements and expanding ad impressions. Despite this, the company faces a massive $130 billion to $145 billion capital expenditure in 2026, causin...
Oracle stock hits new lows amid credit downgrades and AI investment scrutiny
Oracle faces heavy investor pressure after Q4 FY26 results, with credit rating downgrades and rising credit default swap spreads pushing its stock to new lows. The company's negative free cash flow driven by capital expenditures and dependence on deb...
Tesla's China sales drop 12.4% in August, signaling challenges in the world's largest EV market.
Tesla's retail sales in China fell 12.4% in August to 50,047 units, marking its weakest August since 2022 amid a broader 24% decline in China's EV market. While exports from its Shanghai factory rose, the overall weak demand in China and sluggish US ...
Medicus Pharma shifts focus to cancer drug CD228V, advancing melanoma trials and refining other drug programs.
Medicus Pharma is repositioning as a precision oncology biotech, prioritizing its cancer drug candidate CD228V targeting CD228-expressing solid tumors, with initial clinical trials focused on melanoma. The company sees melanoma, especially relapsed o...
Palantir's high valuation risks misreading its consulting-heavy business as pure software success.
Palantir's stock price has soared on strong AI-driven growth, but its business model leans more toward high-touch consulting than scalable software, raising valuation concerns. Despite impressive revenue growth and earnings beats, the company's relia...
Curaleaf rebuts Aurora's claims, defending its $5B acquisition offer as fair and beneficial for shareholders.
Curaleaf Holdings has released a detailed fact sheet countering Aurora Cannabis's criticisms of its $5 billion acquisition proposal. Curaleaf argues its offer includes one of the highest premiums in Canadian M&A history and highlights Aurora's poor f...
Intel shares jump 5% on leading High-NA EUV chip production milestone with ASML's support.
Intel's stock rose 5% following a milestone of processing over one million wafers using advanced High-NA EUV technology from ASML, positioning Intel years ahead in chip manufacturing innovation. ASML and Taiwan Semiconductor also gained 3% amid stron...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.